3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with phenylbutazone in 1 studies
Studies (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Trials (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Recent Studies (post-2010) (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Studies (phenylbutazone) | Trials (phenylbutazone) | Recent Studies (post-2010) (phenylbutazone) |
---|---|---|---|---|---|
100 | 6 | 38 | 6,291 | 317 | 125 |
Protein | Taxonomy | 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (IC50) | phenylbutazone (IC50) |
---|---|---|---|
fMet-Leu-Phe receptor | Homo sapiens (human) | 5.3 | |
Cyclooxygenase-2 | Canis lupus familiaris (dog) | 3.79 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, M; Maruyama, T; Matsunaga, H; Otagiri, M; Takadate, A; Tsutsumi, Y | 1 |
1 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and phenylbutazone
Article | Year |
---|---|
Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin.
Topics: Bilirubin; Binding Sites; Binding, Competitive; Dicarboxylic Acids; Furans; Humans; Hydrogen-Ion Concentration; Ligands; Phenylbutazone; Propionates; Protein Conformation; Serum Albumin; Warfarin | 1999 |